Assesses Lambert-Eaton myasthenic syndrome (LEMS) severity using the QMG-LEMS score, VGCC antibody titer, paraneoplastic SCLC screening priority score, and 3,4-diaminopyridine dosing.
Assesses Lambert-Eaton myasthenic syndrome (LEMS) severity using the QMG-LEMS score, VGCC antibody titer, paraneoplastic SCLC screening priority score, and 3,4-diaminopyridine dosing
Each component has a specific meaning:
Note: Interpret the lems score result against the thresholds and context described above.
Enter the VGCC antibody titer, 3, 4-diaminopyridine dosing for the scenario you are assessing. Assesses Lambert-Eaton myasthenic syndrome (LEMS) severity using the QMG-LEMS score, VGCC antibody titer, paraneoplastic SCLC screening priority score, and 3,4-diaminopyridine dosing. Use the lems score result to inform your calculation.